Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests

被引：28

作者：

Nath, Himadri ^{[1
]}

Mallick, Abinash ^{[1
]}

Roy, Subrata ^{[1
]}

Sukla, Soumi ^{[2
]}

Basu, Keya ^{[3
,4
]}

De, Abhishek ^{[5
]}

Biswas, Subhajit ^{[1
]}

机构：

[1] CSIR Indian Inst Chem Biol CSIR IICB, Infect Dis & Immunol Div, 4 Raja SC Mullick Rd, Kolkata 700032, W Bengal, India

[2] Natl Inst Pharmaceut Educ & Res, 168 Maniktala Main Rd, Kolkata 700054, W Bengal, India

[3] Inst Postgrad Med Educ & Res IPGMER, Dept Pathol, 244 Acharya Jagadish Chandra Bose Rd, Kolkata 700020, W Bengal, India

[4] Seth Sukhlal Karnani Mem SSKM Hosp, 244 Acharya Jagadish Chandra Bose Rd, Kolkata 700020, W Bengal, India

[5] Calcutta Natl Med Coll & Hosp, Dept Dermatol, Kolkata 700014, W Bengal, India

来源：

JOURNAL OF MEDICAL MICROBIOLOGY | 2021年 / 70卷 / 06期

关键词：

dengue virus; SARS-CoV-2; COVID-19; false-positive; antibody test; cross-reactive; strip test;

D O I：

10.1099/jmm.0.001369

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Co-endemicity of SARS-CoV-2 and dengue virus (DV) infection is becoming a matter of serious concern as it has been already reported that antibodies (Ab) elicited by SARS-CoV-2 infection can produce false-positive results in dengue IgG and IgM rapid tests and vice versa. Here we communicate that five of thirteen DV antibody-positive serum samples from Kolkata, archived in 2017 (predating the COVID-19 outbreak), produced false-positive results in SARS-CoV-2 IgG/IgM lateral flow-based rapid tests. Our results emphasize the importance of implementing tests with higher specificity to conduct sero-surveillance for accurate estimation of SARS-CoV-2/DV prevalence in regions where both viruses now co-exist.

引用

页数：5

共 15 条

[1] [Anonymous], NATL VECTOR BORNE DI
[2] [Anonymous], CORONAVIRUS DIS COVI
[3] The global distribution and burden of dengue
Bhatt, Samir
Gething, Peter W.
Brady, Oliver J.
Messina, Jane P.
Farlow, Andrew W.
Moyes, Catherine L.
Drake, John M.
Brownstein, John S.
Hoen, Anne G.
Sankoh, Osman
Myers, Monica F.
George, Dylan B.
Jaenisch, Thomas
Wint, G. R. William
Simmons, Cameron P.
Scott, Thomas W.
Farrar, Jeremy J.
Hay, Simon I.
[J]. NATURE, 2013, 496 (7446) : 504 - 507
[4] Hicks Jennifer, 2020, medRxiv, DOI 10.1101/2020.06.22.20137695
[5] Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses
Lustig, Yaniv
Keler, Shlomit
Kolodny, Rachel
Ben-Tal, Nir
Atias-Varon, Danit
Shlush, Ekaterina
Gerlic, Motti
Munitz, Ariel
Doolman, Ram
Asraf, Keren
Shlush, Liran, I
Vivante, Asaf
[J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) : E2444 - E2449
[6] Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
Lv, Huibin
Wu, Nicholas C.
Tsang, Owen Tak-Yin
Yuan, Meng
Perera, Ranawaka A. P. M.
Leung, Wai Shing
So, Ray T. Y.
Chan, Jacky Man Chun
Yip, Garrick K.
Chik, Thomas Shiu Hong
Wang, Yiquan
Choi, Chris Yau Chung
Lin, Yihan
Ng, Wilson W.
Zhao, Jincun
Poon, Leo L. M.
Peiris, J. S. Malik
Wilson, Ian A.
Mok, Chris K. P.
[J]. CELL REPORTS, 2020, 31 (09):
[7] Nath H, 2020, DENGUE ANTIBODIES CA
[8] NathH MallickA, COMPUT STRUCT BIOTEC, V19, P459
[9] Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
Shrock, Ellen
Fujimura, Eric
Kula, Tomasz
Timms, Richard T.
Lee, I-Hsiu
Leng, Yumei
Robinson, Matthew L.
Sie, Brandon M.
Li, Mamie Z.
Chen, Yuezhou
Logue, Jennifer
Zuiani, Adam
McCulloch, Denise
Lelis, Felipe J. N.
Henson, Stephanie
Monaco, Daniel R.
Travers, Meghan
Habibi, Shaghayegh
Clarke, William A.
Caturegli, Patrizio
Laeyendecker, Oliver
Piechocka-Trocha, Alicja
Li, Jonathan Z.
Khatri, Ashok
Chu, Helen Y.
Villani, Alexandra-Chloe
Kays, Kyle
Goldberg, Marcia B.
Hacohen, Nir
Filbin, Michael R.
Yu, Xu G.
Walker, Bruce D.
Wesemann, Duane R.
Larman, H. Benjamin
Lederer, James A.
Elledge, Stephen J.
[J]. SCIENCE, 2020, 370 (6520) : 1058 - +
[10] Spinicci M, 2020, MEM I OSWALDO CRUZ, V115

← 1 2 →